General Abstract & Application Information
Important 2016 Abstract & Application Dates
|August 8||Regular Abstract & Late-Breaking Abstract Application Submission Period Closed|
|August 8||Young Investigator Award Abstract Submission Period Closed|
|August 8||New Cancer Immunotherapy Agents in Development Presentation Application Submission Period Closed|
|September 7||Late-Breaking Abstract Submission Period Opens*|
|September 21||Late-Breaking Abstract Submission Period Closes|
|September 26||Regular Abstract Titles Available via SITC 2016 Meeting App|
|November 8||Embargo Date (For Regular and Late-Breaking Abstracts)|
|November 8||Publish Date (Regular Abstracts ONLY)|
|December 8||Publish Date (Late-Breaking Abstracts ONLY)|
|*Those who were interested in submitting a Late-Breaking Abstract needed to submit an application by August 8, 2016. Only those who submitted an application will be eligible to submit during the Late-Breaking Abstract period.|
31st Annual Meeting Regular Abstract Information
Submission Period & Details
Regular abstracts were accepted from Friday, April 1 through Monday, August 8, 2016 at 11:59 p.m. EDT.
- Young Investigator Awards are offered in conjunction with regular abstract submission
- Opportunity to give oral abstract presentations within Annual Meeting sessions
- All accepted abstracts will be available to 31st Annual Meeting attendees in program materials and published in the Journal for ImmunoTherapy of Cancer, the Society's own global, open access, peer-reviewed journal
Questions? Check out our list of FAQs!
31st Annual Meeting Late-Breaking Abstract Information
Late-breaking abstract submission is solely for abstracts with late-breaking data and not for abstracts submitted "late". Those who were interested in submitting a Late-Breaking Abstract needed to submit an application by August 8, 2016. Only those who submitted an application will be eligible to submit during the Late-Breaking Abstract period. For information, click here.
New Cancer Immunotherapy Agents in Development Presentation Application
SITC accepted applications to present within the New Cancer Immunotherapy Agents in Development program taking place on November 9, 2016. For information, click here.